Müller RH - Search Results

1

Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.

Kasongo KW, Shegokar R, Müller RH, Walker RB. Kasongo KW, et al. Among authors: muller rh. Drug Dev Ind Pharm. 2011 Apr;37(4):396-407. doi: 10.3109/03639045.2010.516264. Epub 2010 Oct 6. Drug Dev Ind Pharm. 2011. PMID: 20923388

2

Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain.

Kasongo KW, Jansch M, Müller RH, Walker RB. Kasongo KW, et al. Among authors: muller rh. J Liposome Res. 2011 Sep;21(3):245-54. doi: 10.3109/08982104.2010.539186. Epub 2010 Dec 21. J Liposome Res. 2011. PMID: 21174528

3

The use of hot and cold high pressure homogenization to enhance the loading capacity and encapsulation efficiency of nanostructured lipid carriers for the hydrophilic antiretroviral drug, didanosine for potential administration to paediatric patients.

Kasongo KW, Müller RH, Walker RB. Kasongo KW, et al. Among authors: muller rh. Pharm Dev Technol. 2012 May-Jun;17(3):353-62. doi: 10.3109/10837450.2010.542163. Epub 2011 Jan 17. Pharm Dev Technol. 2012. PMID: 21241166

4

Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers.

Kasongo KW, Pardeike J, Müller RH, Walker RB. Kasongo KW, et al. Among authors: muller rh. J Pharm Sci. 2011 Dec;100(12):5185-96. doi: 10.1002/jps.22711. Epub 2011 Jul 24. J Pharm Sci. 2011. PMID: 22020815

5

Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.

Shegokar R, Müller RH. Shegokar R, et al. Among authors: muller rh. Int J Pharm. 2010 Oct 31;399(1-2):129-39. doi: 10.1016/j.ijpharm.2010.07.044. Epub 2010 Jul 30. Int J Pharm. 2010. PMID: 20674732 Review.

6

In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy.

Shegokar R, Jansch M, Singh KK, Müller RH. Shegokar R, et al. Among authors: muller rh. Nanomedicine. 2011 Jun;7(3):333-40. doi: 10.1016/j.nano.2010.10.012. Epub 2010 Nov 19. Nanomedicine. 2011. PMID: 21094278

7

20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications.

Müller RH, Shegokar R, Keck CM. Müller RH, et al. Curr Drug Discov Technol. 2011 Sep;8(3):207-27. doi: 10.2174/157016311796799062. Curr Drug Discov Technol. 2011. PMID: 21291409 Review.

8

Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.

Mitri K, Shegokar R, Gohla S, Anselmi C, Müller RH. Mitri K, et al. Among authors: muller rh. Int J Pharm. 2011 Jul 29;414(1-2):267-75. doi: 10.1016/j.ijpharm.2011.05.008. Epub 2011 May 7. Int J Pharm. 2011. PMID: 21596122

9

Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation.

Al Shaal L, Shegokar R, Müller RH. Al Shaal L, et al. Among authors: muller rh. Int J Pharm. 2011 Nov 25;420(1):133-40. doi: 10.1016/j.ijpharm.2011.08.018. Epub 2011 Aug 17. Int J Pharm. 2011. PMID: 21871547

10

Lutein nanocrystals as antioxidant formulation for oral and dermal delivery.

Mitri K, Shegokar R, Gohla S, Anselmi C, Müller RH. Mitri K, et al. Among authors: muller rh. Int J Pharm. 2011 Nov 25;420(1):141-6. doi: 10.1016/j.ijpharm.2011.08.026. Epub 2011 Aug 23. Int J Pharm. 2011. PMID: 21884768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters